A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/01/2006	CN1282638C Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282487C Sustained release medicine for artificially inducing sex reversal of grouper and its preparation method
11/01/2006	CN1282484C Lipid reducing and regulating agent
11/01/2006	CN1282483C Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use
11/01/2006	CN1282479C Slowly-released traditional Chinese medicine adhering tablet for treating mouth mucous diseases and its prepn. method
11/01/2006	CN1282466C Preparation extracted from stephania tetrandra S. Moor and the use thereof
11/01/2006	CN1282459C Progesterone capsule and preparing method thereof
11/01/2006	CN1282458C Cefadroxil dry suspension and preparing method
11/01/2006	CN1282457C Composite for treating hyperlipidemia
11/01/2006	CN1282456C Paroxetine control-released composite
11/01/2006	CN1282455C Radiation resistant medicament of ginko flavone and tea polyphenol
11/01/2006	CN1282454C Oral composition for hydrating mammal skin and kit and method thereof
11/01/2006	CN1282453C Medication for treating oral disease
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
11/01/2006	CN1282425C Apple vinegar nutritious product and its producing method
11/01/2006	CN1282419C 油组合物 Oil composition
10/2006
10/31/2006	US7129379 3-amino-propoxphenyl derivatives (l)
10/31/2006	US7129378 Method of preparing amine stereoisomers
10/31/2006	US7129377 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
10/31/2006	US7129374 Catalytic antioxidants and methods of use
10/31/2006	US7129368 Platinum carboxylate anticancer compounds
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006	US7129359 for treating infection by enterovirus of the Picornaviridae family ; exemplified by: 1-[2-(4'-Chloro-biphenyl-4-yloxymethyl)-benzyl]-3-pyridin-4-yl-imidazolidin-2-one
10/31/2006	US7129358 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc.
10/31/2006	US7129357 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129352 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
10/31/2006	US7129351 Pyrimido compounds having antiproliferative activity
10/31/2006	US7129349 Methods of synthesizing 3-amino-1,2,4-benzotriazines
10/31/2006	US7129345 Keto-substituted steroid compounds
10/31/2006	US7129308 Functionalized silicon compounds and methods for their synthesis and use
10/31/2006	US7129307 Functionalized silicon compounds and methods for their synthesis and use
10/31/2006	US7129299 Sulphonated comb polymers having a selected lithium/sodium ratio and preparations including such polymers
10/31/2006	US7129275 Compositions for treating acne comprising phytandiol amine
10/31/2006	US7129274 well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals
10/31/2006	US7129273 Combining approximately two cations of creatine with one malic acid dianion into a single compound has shown to be much more effective and more readily absorbed than any other form of creatine or malic acid supplement currently available
10/31/2006	US7129272 Apoptosis inhibitor
10/31/2006	US7129271 Compounds for pest control and methods for their use
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129269 Compound
10/31/2006	US7129268 Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
10/31/2006	US7129267 Methods for SHP1 mediated neuroprotection
10/31/2006	US7129266 its production by fermentation, to methods for its recovery and concentration from the crude solutions, and to a process for its purification
10/31/2006	US7129265 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
10/31/2006	US7129264 anticoagulants; antiinflammatory agents; cardiovascular disorders
10/31/2006	US7129263 Preparation of 3-azabicyclo [3.1.0] hexane derivatives
10/31/2006	US7129262 Effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent.
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129260 Isoindolinone kinase inhibitors
10/31/2006	US7129259 Halogenated biaryl heterocyclic compounds and methods of making and using the same
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129256 Antiparkinsonism drugs
10/31/2006	US7129255 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
10/31/2006	US7129253 Compounds
10/31/2006	US7129252 Six membered amino-amide derivatives an angiogenisis inhibitors
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006	US7129250 Neuroprotective and anti-proliferative compounds
10/31/2006	US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
10/31/2006	US7129248 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129244 Triazolopyrimidines and related analogs as HSP90-inhibitors
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129239 Dietetics; cardiovascular disorders; strokes; antidiabetic agents, sleep disorders, osteoporosis
10/31/2006	US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006	US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129235 Amides useful for treating pain
10/31/2006	US7129234 Selective serotonin re-uptake inhibitors
10/31/2006	US7129233 Competitive and selective inhibitors of trypsin-like serine proteases involved in hemostasis; anticoagulants; e.g., 1-((1-haloalkoxy)phenyl)-),2-(hydroxy),ethyl)carbonyl-),2-((4-amidinopyrid-1-yl)methaminocarbonyl)pyrrole
10/31/2006	US7129232 For therapy of of infectious diseases
10/31/2006	US7129231 Regulation of intracellular glucocorticoid concentrations
10/31/2006	US7129230 Method and product for treating cancer in pets
10/31/2006	US7129229 Hydrazide building blocks and hydrazide modified biomolecules
10/31/2006	US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006	US7129227 Herpes, hepatitis and aids virus; administering phosphatides
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	US7129224 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
10/31/2006	US7129223 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
10/31/2006	US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006	US7129221 6,11-bicyclic erythromycin derivatives
10/31/2006	US7129220 Substituted indole-O-glucosides
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7129218 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
10/31/2006	US7129217 starting material for high-quality polyacrylamide; microbial enzyme is used instead of a copper catalyst, nitrile hydratase, to produce acrylamide from acrylonitrile
10/31/2006	US7129080 Vitro model of priocidal activity
10/31/2006	US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives
10/31/2006	US7128932 Formulations useful in the treatment of male and female impotence
10/31/2006	US7128930 Topically administering to the genitals of a patient with sexual dysfunction an ethyl ester of L-arginine, combination of ascorbic acid and ascorbic acid palmitate as antioxidants to cause the desired level of blood flow to erectile tissue while minimizing peroxynitrite levels
10/31/2006	US7128928 Ophthalmic formulation with novel gum composition
10/31/2006	US7128926 Ester compound and use thereof
10/31/2006	US7128923 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders
10/31/2006	US7128903 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same

1 ... 4030 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 ... 7860